Warning! GuruFocus detected
1 Severe warning sign
with SLRX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Salarius Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US33938A1051
Description
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.98 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 31.3 | |||||
| 3-Year EPS without NRI Growth Rate | 33.3 | |||||
| 3-Year FCF Growth Rate | 38 | |||||
| 3-Year Book Growth Rate | -61.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.14 | |||||
| 9-Day RSI | 27.95 | |||||
| 14-Day RSI | 32.2 | |||||
| 3-1 Month Momentum % | 12.93 | |||||
| 6-1 Month Momentum % | 6.41 | |||||
| 12-1 Month Momentum % | -66.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.09 | |||||
| Quick Ratio | 4.09 | |||||
| Cash Ratio | 3.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -60.5 | |||||
| Shareholder Yield % | -84.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -122.85 | |||||
| ROA % | -91.49 | |||||
| ROIC % | -1772.08 | |||||
| 3-Year ROIIC % | 47.09 | |||||
| ROCE % | -128.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.47 | |||||
| Price-to-Tangible-Book | 0.47 | |||||
| EV-to-EBIT | 0.27 | |||||
| EV-to-EBITDA | 0.27 | |||||
| EV-to-FCF | 0.26 | |||||
| Price-to-Net-Current-Asset-Value | 0.48 | |||||
| Price-to-Net-Cash | 0.59 | |||||
| Earnings Yield (Greenblatt) % | 370.37 | |||||
| FCF Yield % | -349.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Salarius Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -6.42 | ||
| Beta | 0.23 | ||
| 3-Year Sharpe Ratio | -1.15 | ||
| 3-Year Sortino Ratio | -1.34 | ||
| Volatility % | 84.12 | ||
| 14-Day RSI | 32.2 | ||
| 14-Day ATR ($) | 0.202061 | ||
| 20-Day SMA ($) | 1.331225 | ||
| 12-1 Month Momentum % | -66.53 | ||
| 52-Week Range ($) | 0.9 - 7.2 | ||
| Shares Outstanding (Mil) | 1.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Salarius Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Salarius Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Salarius Pharmaceuticals Inc Frequently Asked Questions
What is Salarius Pharmaceuticals Inc(SLRX)'s stock price today?
The current price of SLRX is $0.96. The 52 week high of SLRX is $7.20 and 52 week low is $0.90.
When is next earnings date of Salarius Pharmaceuticals Inc(SLRX)?
The next earnings date of Salarius Pharmaceuticals Inc(SLRX) is 2025-03-14 Est..
Does Salarius Pharmaceuticals Inc(SLRX) pay dividends? If so, how much?
Salarius Pharmaceuticals Inc(SLRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers